Novartis AG's OTC Unit Messes Up Again, Recalls 4 Million Bottles of Maalox

Novartis AG recalled 4.4 million bottles of its antacid medicine Maalox because the lot numbers or expiration dates weren't legible on the outer plastic packaging, U.S. regulators said. Novartis initiated the voluntary recall on Aug. 6 for nine different types of the chewable tablets, including Extra Strength and Advanced Maximum Strength Antacid and Antigas.

Help employers find you! Check out all the jobs and post your resume.